Mereo BioPharma (MREO) Other Operating Expenses (2025 - 2026)
Mereo BioPharma (MREO) posted quarterly Other Operating Expenses of $2.0 million for Q1 2026, up 221.48% year-over-year from $636735.3 in Q1 2025, and up 582.33% quarter-over-quarter from $300000.0 in Q3 2025.
Mereo BioPharma (MREO) Other Operating Expenses (2025 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Other Operating Expenses for 2 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 221.48% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.3 million (up 239.29% YoY), while the FY2022 annual figure was $951244.9, changed N/A from the prior year.
- Other Operating Expenses rose to $2.0 million in Q1 2026 per MREO's latest filing, from $300000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.0 million in Q1 2026 and bottomed at -$1.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25,000.00 |
| Mar 31, 2026 | 2.05 Mn |
| Sep 30, 2025 | 300,000.00 |
| Mar 31, 2025 | -1.69 Mn |